Your session is about to expire
← Back to Search
Procedure
Arthroscopic Stabilization vs Latarjet Procedure for Shoulder Dislocation (STABLE-2 Trial)
N/A
Recruiting
Led By Moin Khan, MD
Research Sponsored by McMaster University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights
No Placebo-Only Group
Summary
This trial tests if two shoulder repair surgeries have different effects on recovery time and function 24 months later.
Who is the study for?
This trial is for men and women aged 18-50 with recurrent shoulder dislocations, specifically those who've had at least two documented episodes. They should have mild bone loss in the shoulder joint but can't be pregnant, have other shoulder injuries, a history of seizures, or any legal or insurance claims related to their injury.
What is being tested?
The STABLE trial is comparing two surgical procedures for recurrent shoulder dislocation: the arthroscopic Bankart Procedure (with or without Remplissage) versus the Latarjet procedure. The goal is to see which one gives better functional recovery after 24 months.
What are the potential side effects?
Potential side effects from these surgeries may include pain at the surgery site, infection risk, limited range of motion, nerve damage around the operated area, and possible re-dislocation or instability of the shoulder.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Clinical Outcome - Shoulder function
Secondary study objectives
Clinical Outcome
Clinical Outcome - Quality of Life
Clinical Outcome - Shoulder activity
+5 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Latarjet ProcedureExperimental Treatment1 Intervention
Open or Arthroscopic coracoid transfer (Latarjet Procedure): This procedure may be performed through small incisions (minimally invasive) but may require a larger incision in some cases. It involves the transfer of a nearby bony structure (the coracoid process) to the front of the shoulder joint (glenoid). This bone will then provide support to prevent the shoulder joint from dislocating.
Group II: Bankart + Remplissage ProcedureExperimental Treatment1 Intervention
Bankart Procedure: the participant will be placed in the lateral decubitus or beach chair position. Standard diagnostic arthroscopy will be performed. The anterior capsulolabral complex will be freed from the anterior aspect of the scapular neck. The anterior aspect of the scapular neck will be decorticated using a motorized burr. A capsuloligamentous repair will be performed with the capsule shifted from inferior to superior and repaired on the glenoid face. The number of anchors used for the repair will be left to the discretion of the surgeon. Patients will be given a sling for 4 weeks, and participation in sports will not be allowed for 6 months.
Find a Location
Who is running the clinical trial?
McMaster UniversityLead Sponsor
918 Previous Clinical Trials
2,616,179 Total Patients Enrolled
Moin Khan, MDPrincipal InvestigatorMcMaster University
4 Previous Clinical Trials
446 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have epilepsy or a seizure disorder.I have had shoulder surgery in the past.My shoulder has dislocated at least twice due to injury.I have been diagnosed with joint instability in multiple directions.I am between 18 and 50 years old.I have mild shoulder socket bone loss (10-20%).
Research Study Groups:
This trial has the following groups:- Group 1: Bankart + Remplissage Procedure
- Group 2: Latarjet Procedure
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.